Skip to search formSkip to main contentSkip to account menu

HM91 Regimen

Known as: COP-COPADM-VEBBP-Sequence I Regimen, HM91, SFOP-HM91 Regimen 
A regimen administered in four phases that is used for the treatment of disseminated, childhood, anaplastic large cell lymphoma (ALCL). The treatment… 
National Institutes of Health

Related topics

Related topics

9 relations
BleomycinChildhood Anaplastic Large Cell LymphomaCyclophosphamideDoxorubicin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Congres IAPD-SFOP Paris 2001.
1996
1996
[13th meeting of the French Society for Pediatric Oncology and Psychiatry (SFOP-Psy). Paris, 23 June 1995. Therapeutic decision in pediatric oncology].
1995
1995
528 Results of HM91 protocol of the french pediatric oncology society (SFOP) for children with large cell anaplasic lymphoma
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)